lOMoARcPSD|285 053 80 ii
lOMoARcPSD|285 053 80 ii
ii
ATI Pharmacology Proctor 2025 (Questions)
ii ii ii ii ii
Verified Correct Answers Latest Update
ii ii ii ii ii
Already Pass 100% Accurate
ii ii ii ii ii
1.) iiA iinurse iiis iiassessing iia iiclient iiwho iiis iireceiving iiintravenous iitherapy. iiThe iinurse iishould iiidentify
iiwhich iiof iithe iifollowing iifindings iias iia iimanifestation iiof iifluid iivolume iiexcess? ii
a. iiDecreased iibowel iisounds ii
b. iiDistended iineck iiveins ii ii
c. Bilateral iimuscle iiweakness ii
d. Thread iipulse ii
2.) iiA iinurse iiis iicaring iifor iia iiclient iiwho iihas iihyponatremia iiand iiis iireceiving iian iiinfusion iiof iia
iiprescribed iihypertonic iisolution. iiWhich iiof iithe iifollowing iifindings iishould iiindicate iito iithe
iinurse iithat iithe iitreatment iiis iieffective? ii
a. iiAbsent iiChvostek9s iisign ii
b. iiImproved iicognition ii ii
c. Decreased iivomiting ii
d. Cardiac iiarrhythmias iiabsent ii
3.) iiA iinurse iiis iiteaching iia iiclient iiwho iihas iia iinew iiprescription iifor iia iinitroglycerin iitransdermal
iipatch. ii
Which iiof iithe iifollowing iiinstructions iishould iithe iinurse iiinclude? ii
a. <Discontinue iithe iipatch iiif iiyou iiexperience iia iiheadache.= ii
b. <Apply iia iinew iipatch iiif iiyou iihave iichest iipain.= ii
c. <Cover iithe iipatch iiwith iidry iigauze iiwhen iitaking iia iishower.= ii
d. ii<Remove iithe iipatch iiprior iito iigoing iito iibed.= ii ii
4.) A iinurse iiis iireviewing iihe iilaboratory iiresults iiof iia iiclient iiwho iihas iia iiprescription iifor iisodium
iipolystyrene iisulfonate ii(Kayexalate) iievery ii6 iihr. iiwhich iiof iithe iifollowing iishould iithe iinurse
iireport iito iithe iiprovider? ii
a. Creatinine ii0.72 iimg/dL ii
b. Sodium ii138 iimEq/L ii
c. Magnesium ii2 iimEq/L ii
d. Potassium ii5.2 iimEq/L ii- iiHyperkalemia ii(serum iipotassium iilevel iigreater iithan ii5.0
iimEq/L) iiincreases iithe iiclient iirisk iifor iifatal iicardiac iidysrhythmias. iiKayexalate iiis iiused iito
iidecrease iithe iiserum iipotassium iilevel, iiso iithe iiPN iishould iimonitor iithe iiclient's iiserum
iipotassium iilevel ii
5.) A iinurse iiis iicaring iifor iia iiclient iiwho iihas iituberculosis iiand iiis iitaking iiisoniazid iiand iirifampin.
iiWhich iiof iithe iifollowing iioutcomes iiindicates iithat iithe iiclient iiis iiadhering iito iithe iimedication
iiregimen? ii
a. iiThe iiclient iihas iia iinegative iisputum iiculture ii
b. The iiclient iitests iinegative iifor iiHIV ii
, lOMoARcPSD|285 053 80 ii
c. The iiclient iihas iia iipositive iipurified iiprotein iiderivative iitest ii
d. The iiclient9s iiliver iifunction iitest iiresults iiare iiwithin iithe iiexpected iireference iirange ii
6.) iiA iiclient iiis iicaring iifor iia iiclient iiwho iidevelops iian iianaphylactic iireaction iito iiIV iiadministration.
iiAfter iiassessing iithe iiclient9s iirespiratory iistatus iiand iistopping iithe iimedication iiinfusion.
iiWhich iiof iithe iifollowing iiactions iishould iithe iinurse iitake iinext? ii
a. Replace iithe iiinfusion iiwith ii0.9% iisodium iichloride ii
b. Give iidiphenhydramine iiIM ii
c. Elevate iithe iiclient9s iilegs iiand iifeet ii
d. iiAdminister iiepinephrine iiIM ii
ii
ii
ii
ii
ii
7.) A iinurse iiis iicaring iifor iia iiclient iiwho iiis iitaking iisertraline iiand iireports iia iidesire iito iibegin iitaking
iisupplements. iiWhich iiof iithe iifollowing iisupplements iishould iithe iinurse iiadvise iithe iiclient iito
iiavoid? iia. iiSt. iiJohn9s iiWort ii ii
b. Ginger iiroot ii
c. Black iicohosh ii
d. Coenzyme iiQ10 ii
8.) A iinurse iiis iicaring iifor iia iiclient iiwho iihas iiheart iifailure iiand iia iinew iiprescription iifor iilisinopril.
iiFor iiwhich iiof iithe iifollowing iiadverse iieffects iishould iithe iinurse iimonitor iiwhen iiadministering
iilisinopril? iia. iiBradycardia ii
b. Hypokalemia ii
c. Tinnitus ii
d. iiHypotension ii
9.) iiA iinurse iiis iiassessing iia iiclient iiwho iiis iireceiving iiheparin iiIV iicontinuous iiIV. iiThe iiclient iihas iian
iiPPT iiof ii90 iiseconds. iiThey iishould iimonitor iithe iiclient iifor iiwhich iiof iithe iifollowing iichanges iiin
iitheir iivital iisigns? iia. iiDecreased iitemperature ii
b. Increased iipulse iirate ii
c. Decreased iirespiratory iirate ii
d. iiIncreased iiblood iipressure ii ii
10.) iiA iinurse iiis iipreparing iito iiadminister iimedication iito iia iiclient iiand iidiscovers iia iimedication
iierror. iiThe iinurse iishould iirecognize iithat iiwhich iiof iithe iifollowing iistaff iimembers iiis
iiresponsible iifor iicompleting iian iiincident iireport? ii
a. iiThe iiquality iiimprovement iicommittee ii
b. iiThe iinurse iiwho iiidentifies iithe iierror ii ii
c. The iinurse iiwho iicaused iithe iierror ii
d. The iicharge iinurse ii
11.) A iinurse iiis iiplanning iicare iifor iia iiclient iiwho iiis iireceiving iimorphine iivia iicontinuous iiepidural
iiinfusion. ii
The iinurse iishould iimonitor iithe iiclient iifor iiwhich iiof iithe iifollowing? ii
a. Pruritus ii3 iiSign iiof iiallergic iireaction iito iimorphine ii
b. Cough ii
, lOMoARcPSD|285 053 80 ii
ii
c. Tachypnea ii
d. Gastric iibleeding ii
12.) A iinurse iiis iipreparing iito iiadminister iidigoxin iiorally iito iia iiclient. iiIdentify iithe iisequence iiof
iisteps iithe iinurse iishould iitake. ii(Move iithe iisteps iiinto iithe iibox iion iithe iiright,
iiplacing iithem iiin iithe iiorder iiof iiperformance. iiUse iiall iithe iisteps.) ii
a. iiObtain ii ii ii ii ii ii ii ii ii ii ii ii iithe ii ii ii ii ii ii ii ii ii ii ii ii iiclient9s ii ii ii ii ii ii ii ii ii ii ii ii iiapical ii ii ii ii ii ii ii
ii ii ii ii ii ii iiheart ii ii ii ii ii ii ii ii ii ii ii ii ii iirate iib. ii ii ii ii ii ii iiRemove ii ii ii ii ii iithe ii ii ii ii ii iimedication ii ii ii ii ii
iifrom ii ii ii ii ii iithe ii ii ii ii ii iidispensing ii ii ii ii ii iisystem iic. iiOpen ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii
iithe ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii medication ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii package ii
d. iiCompare iithe iiclient9s iiwristband iito iithe iimedication iiadministration
iirecord
ii
e. iiDocument administration
ii ii of the
ii
iimedication ii
ii
ii
ii
ii
13.) iiA iinurse iiis iireviewing iithe iimedical iirecord iiof iian iiadult iiclient iiwho iihas iia iifever iiand iia
iiprescription iifor iiacetaminophen. iiWhich iiof iithe iifollowing iifindings iishould iithe iinurse iiidentify
iias iia iicontraindication ii
for iireceiving iithis iimedication? ii
a. iiAlcohol iiuse iidisorder ii
b. iiChronic iikidney iidisease ii
c. Hepatitis iiB iivaccine iiwithin iithe iilast iiweek ii
d. Diabetes iimellitus ii
14.) iiA iihome iihealth iinurse iiis iivisiting iia iiclient iiwho iihas iiheart iifailure iiand iia iiprescription iifor
iifurosemide. iiThe iinurse iiidentifies iithat iithe iiclient iihas iigained ii2.5 iikg ii(5 iilb.) iisince iithe iilast
iivisit ii2 iidays iiago. iiWhich iiof iithe iifollowing iiactions iishould iithe iinurse iitake iifirst? ii
a. Encourage iithe iiclient iito iidangle iithe iilegs iiwhile iisitting iiin iia iichair ii
b. Teach iithe iiclient iiabout iifoods iilow iiin iisodium ii
c. iiDetermine iimedication iiadherence iiby iithe iiclient ii ii
d. iiNotify iithe iiprovider iiof iithe iiclient9s iiweight iigain ii
15.) A iinurse iiis iipreparing iito iiadminister iithe iiinitial iidose iiof iipenicillin iiG iiIM iito iia iiclient. iiThe iinurse
iishould iimonitor iifor iiwhich iiof iithe iifollowing iias iian iiindication iiof iian iiallergic iireaction iifollowing
iithe iiinjection? iia. iiUrticaria ii ii
b. Bradycardia ii
c. Pallor ii
d. Dyspepsia ii
16.) A iinurse iiis iiteaching iia iiclient iiwho iihas iiangina iia iinew iiprescription iifor iisublingual iinitroglycerin
iitablets. iiWhich iiof iithe iifollowing iiinstructions iishould iithe iinurse iiinclude iiin iithe iiteaching? ii
, lOMoARcPSD|285 053 80 ii
a. <Discard iiany iitablets iiyou iido iinot iiuse iievery ii6 iimonths.= ii
b. <Take iione iitablet iieach iimorning ii30 iiminutes iiprior iito iieating.= ii
c. ii<Keep iithe iitablets iiat iiroom iitemperature iiin iitheir iioriginal iiglass iibotle.= ii
d. ii<Place iithe iitablet iibetween iiyour iicheek iiand iigum iito iidissolve.= ii
17.) iiA iinurse iiis iiproviding iiteaching iito iia iiclient iiwho iihas iia iinew iiprescription iifor
iitheophylline, iia iisustained-released iicapsule. iiWhich iiof iithe iifollowing iistatements iiby
iithe iiclient iiindicates iian iiunderstanding iiof iithe iiteaching? ii
a. ii<I iican iitake iimy iimedication iiin iithe iimorning iiwith iimy iicoffee.= ii
b. <I iimay iisprinkle iithe iimedication iiin iiapplesauce.= ii
c. <I iishould iilimit iimy iifluid iiintake iiwhile iion iithis iimedication.= ii
d. <I iiwill iineed iito iihave iiblood iilevels iidrawn.= ii ii
18.)A iinurse iiis iimixing iiregular iiinsulin iiand iiNPH iiinsulin iiin iithe iisame iisyringe iiprior iito iiadministering
iiit iito iiclient iiwho iihas iidiabetes iimellitus iifollowing iiactions iishould iithe iinurse iitake iifirst? ii
a. Withdraw iithe iiregular iiinsulin iifrom iithe iiviral ii
b. Withdraw iithe iiNPH iiinsulin iiform iithe iivial ii
c. Inject iiair iiinto iithe iiNPH iivial ii ii ii
d. Inject iiair iiinto iithe iiregular iiinsulin iivial ii ii
ii
ii
ii
ii
19.)A iinurse iiis iipreparing iito iiadminister iisubcutaneous iiheparin iito iia iiclient. iiWhich iiof iithe iifollowing
iishould iithe iinurse iitake? ii
a. Massage iithe iisite iiafter iiadministering iithe iimedication ii
b. Use iia ii21-gauge iineedle iifor iithe iiinjection ii
c. Aspirate iibefore iiinjecting iithe iimedication ii
d. iiInsert iithe iineedle iiat iileast ii5 iicm ii(2 iiin) iifrom iithe
iiumbilicus ii
20.)A iinurse iiis iicaring iifor iia iiclient iiwho iihas iia iiprescription iifor iiamoxicillin. iiWhich iiof iithe iifollowing
iifindings iiindicates iithe iiclient iiis iiexperiencing iian iiallergic iireaction? ii
a. iiNausea ii
b. iiCardiac iidysrhythmia ii
c. Laryngeal iiedema ii
d. Insomnia ii
21.)A iinurse iiis iiteaching iia iinewly iilicensed iinurse iiabout iimedication iireconciliation. iiThe iinurse
iishould iiinstruct iithe iinewly iilicensed iinurse iito iiperform iimedication iireconciliation iifor iiwhich
iiof iithe iifollowing? ii
a. A iiclient iiwho iihas iia iireferral iifor iisocial iiservices ii
b. A iiclient iiwho iiis iitransdermal iito iiradiology ii
c. iiA iiclient iiwho iiis iitransferal iito iia iistep-down iiunit ii
d. iiA iiclient iiwho iihas iia iiconsultation iifor iiphysical iitherapy ii
22.)A iinurse iiis iireviewing iithe iilaboratory iivalues iiof iia iiclient iiwho iiis iitaking iiatorvastatin. iiWhich iiof
iithe iifollowing iilaboratory iivalues iiindicates iithe iitreatment iihas iibeen iieffective? ii
a. BUN ii15 iimg/dL ii
lOMoARcPSD|285 053 80 ii
ii
ATI Pharmacology Proctor 2025 (Questions)
ii ii ii ii ii
Verified Correct Answers Latest Update
ii ii ii ii ii
Already Pass 100% Accurate
ii ii ii ii ii
1.) iiA iinurse iiis iiassessing iia iiclient iiwho iiis iireceiving iiintravenous iitherapy. iiThe iinurse iishould iiidentify
iiwhich iiof iithe iifollowing iifindings iias iia iimanifestation iiof iifluid iivolume iiexcess? ii
a. iiDecreased iibowel iisounds ii
b. iiDistended iineck iiveins ii ii
c. Bilateral iimuscle iiweakness ii
d. Thread iipulse ii
2.) iiA iinurse iiis iicaring iifor iia iiclient iiwho iihas iihyponatremia iiand iiis iireceiving iian iiinfusion iiof iia
iiprescribed iihypertonic iisolution. iiWhich iiof iithe iifollowing iifindings iishould iiindicate iito iithe
iinurse iithat iithe iitreatment iiis iieffective? ii
a. iiAbsent iiChvostek9s iisign ii
b. iiImproved iicognition ii ii
c. Decreased iivomiting ii
d. Cardiac iiarrhythmias iiabsent ii
3.) iiA iinurse iiis iiteaching iia iiclient iiwho iihas iia iinew iiprescription iifor iia iinitroglycerin iitransdermal
iipatch. ii
Which iiof iithe iifollowing iiinstructions iishould iithe iinurse iiinclude? ii
a. <Discontinue iithe iipatch iiif iiyou iiexperience iia iiheadache.= ii
b. <Apply iia iinew iipatch iiif iiyou iihave iichest iipain.= ii
c. <Cover iithe iipatch iiwith iidry iigauze iiwhen iitaking iia iishower.= ii
d. ii<Remove iithe iipatch iiprior iito iigoing iito iibed.= ii ii
4.) A iinurse iiis iireviewing iihe iilaboratory iiresults iiof iia iiclient iiwho iihas iia iiprescription iifor iisodium
iipolystyrene iisulfonate ii(Kayexalate) iievery ii6 iihr. iiwhich iiof iithe iifollowing iishould iithe iinurse
iireport iito iithe iiprovider? ii
a. Creatinine ii0.72 iimg/dL ii
b. Sodium ii138 iimEq/L ii
c. Magnesium ii2 iimEq/L ii
d. Potassium ii5.2 iimEq/L ii- iiHyperkalemia ii(serum iipotassium iilevel iigreater iithan ii5.0
iimEq/L) iiincreases iithe iiclient iirisk iifor iifatal iicardiac iidysrhythmias. iiKayexalate iiis iiused iito
iidecrease iithe iiserum iipotassium iilevel, iiso iithe iiPN iishould iimonitor iithe iiclient's iiserum
iipotassium iilevel ii
5.) A iinurse iiis iicaring iifor iia iiclient iiwho iihas iituberculosis iiand iiis iitaking iiisoniazid iiand iirifampin.
iiWhich iiof iithe iifollowing iioutcomes iiindicates iithat iithe iiclient iiis iiadhering iito iithe iimedication
iiregimen? ii
a. iiThe iiclient iihas iia iinegative iisputum iiculture ii
b. The iiclient iitests iinegative iifor iiHIV ii
, lOMoARcPSD|285 053 80 ii
c. The iiclient iihas iia iipositive iipurified iiprotein iiderivative iitest ii
d. The iiclient9s iiliver iifunction iitest iiresults iiare iiwithin iithe iiexpected iireference iirange ii
6.) iiA iiclient iiis iicaring iifor iia iiclient iiwho iidevelops iian iianaphylactic iireaction iito iiIV iiadministration.
iiAfter iiassessing iithe iiclient9s iirespiratory iistatus iiand iistopping iithe iimedication iiinfusion.
iiWhich iiof iithe iifollowing iiactions iishould iithe iinurse iitake iinext? ii
a. Replace iithe iiinfusion iiwith ii0.9% iisodium iichloride ii
b. Give iidiphenhydramine iiIM ii
c. Elevate iithe iiclient9s iilegs iiand iifeet ii
d. iiAdminister iiepinephrine iiIM ii
ii
ii
ii
ii
ii
7.) A iinurse iiis iicaring iifor iia iiclient iiwho iiis iitaking iisertraline iiand iireports iia iidesire iito iibegin iitaking
iisupplements. iiWhich iiof iithe iifollowing iisupplements iishould iithe iinurse iiadvise iithe iiclient iito
iiavoid? iia. iiSt. iiJohn9s iiWort ii ii
b. Ginger iiroot ii
c. Black iicohosh ii
d. Coenzyme iiQ10 ii
8.) A iinurse iiis iicaring iifor iia iiclient iiwho iihas iiheart iifailure iiand iia iinew iiprescription iifor iilisinopril.
iiFor iiwhich iiof iithe iifollowing iiadverse iieffects iishould iithe iinurse iimonitor iiwhen iiadministering
iilisinopril? iia. iiBradycardia ii
b. Hypokalemia ii
c. Tinnitus ii
d. iiHypotension ii
9.) iiA iinurse iiis iiassessing iia iiclient iiwho iiis iireceiving iiheparin iiIV iicontinuous iiIV. iiThe iiclient iihas iian
iiPPT iiof ii90 iiseconds. iiThey iishould iimonitor iithe iiclient iifor iiwhich iiof iithe iifollowing iichanges iiin
iitheir iivital iisigns? iia. iiDecreased iitemperature ii
b. Increased iipulse iirate ii
c. Decreased iirespiratory iirate ii
d. iiIncreased iiblood iipressure ii ii
10.) iiA iinurse iiis iipreparing iito iiadminister iimedication iito iia iiclient iiand iidiscovers iia iimedication
iierror. iiThe iinurse iishould iirecognize iithat iiwhich iiof iithe iifollowing iistaff iimembers iiis
iiresponsible iifor iicompleting iian iiincident iireport? ii
a. iiThe iiquality iiimprovement iicommittee ii
b. iiThe iinurse iiwho iiidentifies iithe iierror ii ii
c. The iinurse iiwho iicaused iithe iierror ii
d. The iicharge iinurse ii
11.) A iinurse iiis iiplanning iicare iifor iia iiclient iiwho iiis iireceiving iimorphine iivia iicontinuous iiepidural
iiinfusion. ii
The iinurse iishould iimonitor iithe iiclient iifor iiwhich iiof iithe iifollowing? ii
a. Pruritus ii3 iiSign iiof iiallergic iireaction iito iimorphine ii
b. Cough ii
, lOMoARcPSD|285 053 80 ii
ii
c. Tachypnea ii
d. Gastric iibleeding ii
12.) A iinurse iiis iipreparing iito iiadminister iidigoxin iiorally iito iia iiclient. iiIdentify iithe iisequence iiof
iisteps iithe iinurse iishould iitake. ii(Move iithe iisteps iiinto iithe iibox iion iithe iiright,
iiplacing iithem iiin iithe iiorder iiof iiperformance. iiUse iiall iithe iisteps.) ii
a. iiObtain ii ii ii ii ii ii ii ii ii ii ii ii iithe ii ii ii ii ii ii ii ii ii ii ii ii iiclient9s ii ii ii ii ii ii ii ii ii ii ii ii iiapical ii ii ii ii ii ii ii
ii ii ii ii ii ii iiheart ii ii ii ii ii ii ii ii ii ii ii ii ii iirate iib. ii ii ii ii ii ii iiRemove ii ii ii ii ii iithe ii ii ii ii ii iimedication ii ii ii ii ii
iifrom ii ii ii ii ii iithe ii ii ii ii ii iidispensing ii ii ii ii ii iisystem iic. iiOpen ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii
iithe ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii medication ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii ii package ii
d. iiCompare iithe iiclient9s iiwristband iito iithe iimedication iiadministration
iirecord
ii
e. iiDocument administration
ii ii of the
ii
iimedication ii
ii
ii
ii
ii
13.) iiA iinurse iiis iireviewing iithe iimedical iirecord iiof iian iiadult iiclient iiwho iihas iia iifever iiand iia
iiprescription iifor iiacetaminophen. iiWhich iiof iithe iifollowing iifindings iishould iithe iinurse iiidentify
iias iia iicontraindication ii
for iireceiving iithis iimedication? ii
a. iiAlcohol iiuse iidisorder ii
b. iiChronic iikidney iidisease ii
c. Hepatitis iiB iivaccine iiwithin iithe iilast iiweek ii
d. Diabetes iimellitus ii
14.) iiA iihome iihealth iinurse iiis iivisiting iia iiclient iiwho iihas iiheart iifailure iiand iia iiprescription iifor
iifurosemide. iiThe iinurse iiidentifies iithat iithe iiclient iihas iigained ii2.5 iikg ii(5 iilb.) iisince iithe iilast
iivisit ii2 iidays iiago. iiWhich iiof iithe iifollowing iiactions iishould iithe iinurse iitake iifirst? ii
a. Encourage iithe iiclient iito iidangle iithe iilegs iiwhile iisitting iiin iia iichair ii
b. Teach iithe iiclient iiabout iifoods iilow iiin iisodium ii
c. iiDetermine iimedication iiadherence iiby iithe iiclient ii ii
d. iiNotify iithe iiprovider iiof iithe iiclient9s iiweight iigain ii
15.) A iinurse iiis iipreparing iito iiadminister iithe iiinitial iidose iiof iipenicillin iiG iiIM iito iia iiclient. iiThe iinurse
iishould iimonitor iifor iiwhich iiof iithe iifollowing iias iian iiindication iiof iian iiallergic iireaction iifollowing
iithe iiinjection? iia. iiUrticaria ii ii
b. Bradycardia ii
c. Pallor ii
d. Dyspepsia ii
16.) A iinurse iiis iiteaching iia iiclient iiwho iihas iiangina iia iinew iiprescription iifor iisublingual iinitroglycerin
iitablets. iiWhich iiof iithe iifollowing iiinstructions iishould iithe iinurse iiinclude iiin iithe iiteaching? ii
, lOMoARcPSD|285 053 80 ii
a. <Discard iiany iitablets iiyou iido iinot iiuse iievery ii6 iimonths.= ii
b. <Take iione iitablet iieach iimorning ii30 iiminutes iiprior iito iieating.= ii
c. ii<Keep iithe iitablets iiat iiroom iitemperature iiin iitheir iioriginal iiglass iibotle.= ii
d. ii<Place iithe iitablet iibetween iiyour iicheek iiand iigum iito iidissolve.= ii
17.) iiA iinurse iiis iiproviding iiteaching iito iia iiclient iiwho iihas iia iinew iiprescription iifor
iitheophylline, iia iisustained-released iicapsule. iiWhich iiof iithe iifollowing iistatements iiby
iithe iiclient iiindicates iian iiunderstanding iiof iithe iiteaching? ii
a. ii<I iican iitake iimy iimedication iiin iithe iimorning iiwith iimy iicoffee.= ii
b. <I iimay iisprinkle iithe iimedication iiin iiapplesauce.= ii
c. <I iishould iilimit iimy iifluid iiintake iiwhile iion iithis iimedication.= ii
d. <I iiwill iineed iito iihave iiblood iilevels iidrawn.= ii ii
18.)A iinurse iiis iimixing iiregular iiinsulin iiand iiNPH iiinsulin iiin iithe iisame iisyringe iiprior iito iiadministering
iiit iito iiclient iiwho iihas iidiabetes iimellitus iifollowing iiactions iishould iithe iinurse iitake iifirst? ii
a. Withdraw iithe iiregular iiinsulin iifrom iithe iiviral ii
b. Withdraw iithe iiNPH iiinsulin iiform iithe iivial ii
c. Inject iiair iiinto iithe iiNPH iivial ii ii ii
d. Inject iiair iiinto iithe iiregular iiinsulin iivial ii ii
ii
ii
ii
ii
19.)A iinurse iiis iipreparing iito iiadminister iisubcutaneous iiheparin iito iia iiclient. iiWhich iiof iithe iifollowing
iishould iithe iinurse iitake? ii
a. Massage iithe iisite iiafter iiadministering iithe iimedication ii
b. Use iia ii21-gauge iineedle iifor iithe iiinjection ii
c. Aspirate iibefore iiinjecting iithe iimedication ii
d. iiInsert iithe iineedle iiat iileast ii5 iicm ii(2 iiin) iifrom iithe
iiumbilicus ii
20.)A iinurse iiis iicaring iifor iia iiclient iiwho iihas iia iiprescription iifor iiamoxicillin. iiWhich iiof iithe iifollowing
iifindings iiindicates iithe iiclient iiis iiexperiencing iian iiallergic iireaction? ii
a. iiNausea ii
b. iiCardiac iidysrhythmia ii
c. Laryngeal iiedema ii
d. Insomnia ii
21.)A iinurse iiis iiteaching iia iinewly iilicensed iinurse iiabout iimedication iireconciliation. iiThe iinurse
iishould iiinstruct iithe iinewly iilicensed iinurse iito iiperform iimedication iireconciliation iifor iiwhich
iiof iithe iifollowing? ii
a. A iiclient iiwho iihas iia iireferral iifor iisocial iiservices ii
b. A iiclient iiwho iiis iitransdermal iito iiradiology ii
c. iiA iiclient iiwho iiis iitransferal iito iia iistep-down iiunit ii
d. iiA iiclient iiwho iihas iia iiconsultation iifor iiphysical iitherapy ii
22.)A iinurse iiis iireviewing iithe iilaboratory iivalues iiof iia iiclient iiwho iiis iitaking iiatorvastatin. iiWhich iiof
iithe iifollowing iilaboratory iivalues iiindicates iithe iitreatment iihas iibeen iieffective? ii
a. BUN ii15 iimg/dL ii
